Point72 Asset Management »

4d Molecular Therapeutics In shares owned by Point72 Asset Management

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Point72 Asset Management from 13F filings

Historical chart of Point72 Asset Management investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by Point72 Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by Point72 Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $8.4M 416k 20.26
2023-09-30 $5.8M 453k 12.73
2023-06-30 $6.7M 371k 18.07
2023-03-31 $3.6M 209k 17.19
2022-12-31 $3.1M 139k 22.21
2022-09-30 $2.4M 299k 8.04